Connection
Matthew McLaughlin to Botulinum Toxins, Type A
This is a "connection" page, showing publications Matthew McLaughlin has written about Botulinum Toxins, Type A.
|
|
Connection Strength |
|
|
|
|
|
1.589 |
|
|
|
-
Sinn CN, Rinaldi RJ, McLaughlin MJ. Botulinum toxin type A outcomes in infants with refractory congenital muscular torticollis. J Pediatr Rehabil Med. 2023; 16(3):539-552.
Score: 0.877
-
McLaughlin MJ, Fisher MT, Vadivelu S, Ramsey J, Ratnasingam D, McGhee E, Hartman K. A risk-stratified approach toward safely resuming OnabotulinumtoxinA injections based on dosing and ambulatory status in pediatric patients with cerebral palsy during the Coronavirus pandemic of 2019 (COVID-19). J Pediatr Rehabil Med. 2020; 13(3):273-279.
Score: 0.712